Gomperts R

No ORCID on file · 2 papers in corpus

other 2026

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.

NPJ breast cancer ·doi:10.1038/s41523-026-00998-x

Women with germline BRCA1 pathogenic variants face a very high risk of early-onset triple-negative breast cancer (TNBC), with risk-reducing mastectomy currently the only established preventive option. Emerging evidence suggests aberrant pro…

other 2024

Mifepristone as a non-emergency contraceptive among women of reproductive age: a protocol for systematic review and meta-analysis

BMJ open ·doi:10.1136/bmjopen-2024-090402

BACKGROUND: Mifepristone is a selective progesterone receptor modulator with decades of data demonstrating its potential as a highly effective emergency as well as non-emergency contraceptive. Despite considerable evidence pointing to the p…